These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 33620145

  • 1. H3.3 K36M Mutation as a Clinical Diagnosis Method of Suspected Chondroblastoma Cases.
    Mu H, Jiang Y, Xue L, Hua Y, Lin J, Cai Z.
    Orthop Surg; 2021 Apr; 13(2):616-622. PubMed ID: 33620145
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Chondroblastoma of foot bones; a clinicopathological study of 29 cases confirming the diagnostic utility of H3K36M and H3G34W antibodies at an uncommon site.
    Tariq MU, Din NU, Qureshi MB, Park YK.
    Ann Diagn Pathol; 2023 Aug; 65():152135. PubMed ID: 37075609
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The H3F3 K36M mutant antibody is a sensitive and specific marker for the diagnosis of chondroblastoma.
    Amary MF, Berisha F, Mozela R, Gibbons R, Guttridge A, O'Donnell P, Baumhoer D, Tirabosco R, Flanagan AM.
    Histopathology; 2016 Jul; 69(1):121-7. PubMed ID: 26844533
    [Abstract] [Full Text] [Related]

  • 9. Clinicopathologic characterization of malignant chondroblastoma: a neoplasm with locally aggressive behavior and metastatic potential that closely mimics chondroblastoma-like osteosarcoma.
    Papke DJ, Hung YP, Schaefer IM, Bredella MA, Charville GW, Reith JD, Fletcher CDM, Nielsen GP, Hornick JL.
    Mod Pathol; 2020 Nov; 33(11):2295-2306. PubMed ID: 32601382
    [Abstract] [Full Text] [Related]

  • 10. Anti-histone H3.3K36M Antibody is a Highly Sensitive and Specific Immunohistochemistry Marker for the Diagnosis of Chondroblastoma. A Validation Based on Study 136 Cases Comprising Chondroblastoma and its Mimics from Single a Centre in India.
    Hui M, Uppin SG, Narayanan R, Kancherla NR, Kamble A, B RR, Patnala C.
    Int J Surg Pathol; 2023 Jun; 31(4):375-386. PubMed ID: 35786027
    [Abstract] [Full Text] [Related]

  • 11. Chondroblastoma-like osteosarcoma: a clinicopathological and molecular study of a rare osteosarcoma variant.
    Gaeta R, Righi A, Gambarotti M, Aretini P, Lessi F, Mazzanti CM, Mancini I, Pinzani P, Belgio B, Sbaraglia M, Tos APD, Franchi A.
    Histopathology; 2022 Sep; 81(3):389-401. PubMed ID: 35791778
    [Abstract] [Full Text] [Related]

  • 12. Chondroblastoma: clinicopathological analyses of 307 cases from a single institution in China and the diagnostic value of the H3F3 K36M mutant antibody.
    Zhao Q, Tang J, Luo Y, Huang J, Hu D, Zhu J, Jiang T, Zhang H, Liu Z.
    J Clin Pathol; 2023 Jun; 76(6):367-373. PubMed ID: 36604179
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic utility of histone H3.3 G34W, G34R, and G34V mutant-specific antibodies for giant cell tumors of bone.
    Yamamoto H, Iwasaki T, Yamada Y, Matsumoto Y, Otsuka H, Yoshimoto M, Kohashi K, Taguchi K, Yokoyama R, Nakashima Y, Oda Y.
    Hum Pathol; 2018 Mar; 73():41-50. PubMed ID: 29241742
    [Abstract] [Full Text] [Related]

  • 14. Expression of SATB2, RUNX2, and SOX9 and possible osteoblastic and chondroblastic differentiation in chondroblastoma.
    Toda Y, Yamamoto H, Iwasaki T, Ishihara S, Ito Y, Susuki Y, Kawaguchi K, Kinoshita I, Kiyozawa D, Yamada Y, Kohashi K, Kimura A, Fujiwara T, Setsu N, Endo M, Matsumoto Y, Nakashima Y, Mawatari M, Oda Y.
    Pathol Res Pract; 2023 Jan; 241():154239. PubMed ID: 36442415
    [Abstract] [Full Text] [Related]

  • 15. [Expression of H3.3 G34W mutant-specific antibody in giant cell tumors of bone and its diagnostic value].
    Wang X, Wu N, Zhang RS, Wei X, Ji RH, Ma HH, Zhou XJ, Rao Q.
    Zhonghua Bing Li Xue Za Zhi; 2020 Feb 08; 49(2):116-121. PubMed ID: 32074722
    [Abstract] [Full Text] [Related]

  • 16. H3F3 mutation status of giant cell tumors of the bone, chondroblastomas and their mimics: a combined high resolution melting and pyrosequencing approach.
    Kervarrec T, Collin C, Larousserie F, Bouvier C, Aubert S, Gomez-Brouchet A, Marie B, Miquelestorena-Standley E, Le Nail LR, Avril P, Christophe Pagès J, de Pinieux G.
    Mod Pathol; 2017 Mar 08; 30(3):393-406. PubMed ID: 28059095
    [Abstract] [Full Text] [Related]

  • 17. Chondroblastoma: An Update.
    Chen W, DiFrancesco LM.
    Arch Pathol Lab Med; 2017 Jun 08; 141(6):867-871. PubMed ID: 28557595
    [Abstract] [Full Text] [Related]

  • 18. Significance of Histone H3.3 (G34W)-Mutant Protein in Pathological Diagnosis of Giant Cell Tumor of Bone.
    Miskad UA, Syamsul F, Dahlan H, Sungowati NK, Achmad D, Johan MP.
    Asian Pac J Cancer Prev; 2023 May 01; 24(5):1737-1741. PubMed ID: 37247296
    [Abstract] [Full Text] [Related]

  • 19. H3F3A-mutated giant cell tumour of bone without giant cells-clinical presentation, radiology and histology of three cases.
    Leinauer B, Wolf E, Werner M, Baumhoer D, Breining T, Luebke AM, Maas R, Schultheiß M, von Baer A, Sufi-Siavach A, Moritz C, Geißler S, Mellert K, Möller P, Barth TFE, Jundt G.
    Histopathology; 2021 Nov 01; 79(5):720-730. PubMed ID: 33991114
    [Abstract] [Full Text] [Related]

  • 20. H3F3A mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant.
    Lüke J, von Baer A, Schreiber J, Lübbehüsen C, Breining T, Mellert K, Marienfeld R, Schultheiss M, Möller P, Barth TFE.
    Histopathology; 2017 Jul 01; 71(1):125-133. PubMed ID: 28211081
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.